10.6084/m9.figshare.4467848.v1 Cédric Bretonnière Cédric Bretonnière Mathieu Jozwiak Mathieu Jozwiak Christophe Girault Christophe Girault Pascal Beuret Pascal Beuret Jean-Louis Trouillet Jean-Louis Trouillet Nadia Anguel Nadia Anguel Jocelyne Caillon Jocelyne Caillon Gilles Potel Gilles Potel Daniel Villers Daniel Villers David Boutoille David Boutoille Christophe Guitton Christophe Guitton Additional file 1: Figure S1. of Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study Springer Nature 2015 Table S 1. Comparison French retrospective cohort ACAM-ICU study Bacteria pneumococcal meningitis Figure S 2. Glasgow Outcome Scale scores Figure S 3. Glasgow Outcome Scale scores community-acquired meningitis ICU admission PDF 157 kb 2015-08-26 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Figure_S1_of_Rifampin_use_in_acute_community-acquired_meningitis_in_intensive_care_units_the_French_retrospective_cohort_ACAM-ICU_study/4467848 Bacteria involved in 136 episodes of meningitis. Figure S2. Glasgow Outcome Scale scores for the groups of patients who did or did not receive rifampin for community-acquired meningitis. Figure S3. Glasgow Outcome Scale scores for the groups of patients who did or not receive early rifampin (within the first 24 h of hospitalization) or not for community-acquired meningitis. Table S1. Comparison of patient characteristics, severity at ICU admission, 9pt?>microbiological data, and therapeutic measures between survivors and non-survivors after ICU admission for pneumococcal meningitis (n=76). Table S2. Factors associated with ICU mortality for a cohort of 76 patients admitted for pneumococcal meningitis. (PDF 157 kb)